Clinical OMICS, a semi-monthly digital publication focusing on the application of OMICs technologies in clinical settings, releases its third issue today. It includes several special features:
- Expect panomics, the integration of multiple omics readouts, to define the pathology report of the future.
- Experts convened by the NIH propose guidelines for interpreting the pathogenicity of gene variants.
- Next-generation sequencers are available that possess clinically relevant features such as ease of use, stability, turnaround time.
In addition, Clinical OMICS No. 3 announces a YouTube page and invites readers and clinical omics specialists to share their expertise.
The current issue’s regular sections also cover the 100K Project, an omics-centric approach to wellness; the widening availability of liquid biopsies, diagnostic tools that rely on circulating biomarkers; and the use of a global phosphorylation assay to guide drug selection for individual patients.
In addition, as always, Clinical OMICS includes news, new products, and a list of handy clinical apps.
Clinical OMICs is directed at clinical lab directors and managers, oncologists, infectious disease specialists, and cardiologists. Intended to serve as a resource for the development and standardization of best OMICs practices, Clinical OMICs provides critical information and insights on the trend toward personalized medicine.
